1. Birth outcomes in Aboriginal mother–infant pairs from the Northern Territory, Australia, who received 23‐valent polysaccharide pneumococcal vaccination during pregnancy, 2006–2011: The PneuMum randomised controlled trial. (14th June 2019) Authors: McHugh, Lisa; Binks, Michael; Ware, Robert S.; Snelling, Tom; Nelson, Sandra; Nelson, Jane; Dunbar, Melissa; Mulholland, E. Kim; Andrews, Ross M. Journal: Australian and New Zealand journal of obstetrics and gynaecology Issue: Volume 60:Number 1(2020) Page Start: 82 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Immunogenicity, otitis media, hearing impairment, and nasopharyngeal carriage 6-months after 13-valent or ten-valent booster pneumococcal conjugate vaccines, stratified by mixed priming schedules: PREVIX_COMBO and PREVIX_BOOST randomised controlled trials. Issue 9 (September 2022) Authors: Leach, Amanda Jane; Wilson, Nicole; Arrowsmith, Beth; Beissbarth, Jemima; Mulholland, Edward Kim; Santosham, Mathuram; Torzillo, Paul John; McIntyre, Peter; Smith-Vaughan, Heidi; Chatfield, Mark D; Lehmann, Deborah; Binks, Michael; Chang, Anne B; Carapetis, Jonathan; Krause, Vicki; Andrews, Ross;... Journal: Lancet infectious diseases Issue: Volume 22:Issue 9(2022) Page Start: 1374 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Innovative Randomized Phase I Study and Dosing Regimen Selection to Accelerate and Inform Pivotal COVID‐19 Trial of Nirmatrelvir. Issue 1 (4th May 2022) Authors: Singh, Ravi Shankar P.; Toussi, Sima S.; Hackman, Frances; Chan, Phylinda L.; Rao, Rohit; Allen, Richard; Van Eyck, Lien; Pawlak, Sylvester; Kadar, Eugene P.; Clark, Frances; Shi, Haihong; Anderson, Annaliesa S.; Binks, Michael; Menon, Sandeep; Nucci, Gianluca; Bergman, Arthur Journal: Clinical pharmacology & therapeutics Issue: Volume 112:Issue 1(2022) Page Start: 101 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Panel 4: Recent advances in understanding the natural history of the otitis media microbiome and its response to environmental pressures. (March 2020) Authors: Marsh, Robyn L.; Aho, Celestine; Beissbarth, Jemima; Bialasiewicz, Seweryn; Binks, Michael; Cervin, Anders; Kirkham, Lea-Ann S.; Lemon, Katherine P.; Slack, Mary P.E.; Smith-Vaughan, Heidi C. Journal: International journal of pediatric otorhinolaryngology Issue: Volume 130(2020)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Pharmacokinetics of Oral Nirmatrelvir/Ritonavir, a Protease Inhibitor for Treatment of COVID‐19, in Subjects With Renal Impairment. Issue 4 (5th July 2022) Authors: Toussi, Sima S.; Neutel, Joel Michael; Navarro, Jesus; Preston, Richard Alfred; Shi, Haihong; Kavetska, Olga; LaBadie, Robert R.; Binks, Michael; Chan, Phylinda L.S.; Demers, Neil; Corrigan, Brian; Damle, Bharat Journal: Clinical pharmacology & therapeutics Issue: Volume 112:Issue 4(2022) Page Start: 892 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Safety, equity and monitoring: a review of the gaps in maternal vaccination strategies for Aboriginal and Torres Strait Islander women. Issue 2 (1st February 2020) Authors: McHugh, Lisa; Crooks, Kristy; Creighton, Amy; Binks, Michael; Andrews, Ross M Journal: Human vaccines & immunotherapeutics Issue: Volume 16:Issue 2(2020) Page Start: 371 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Safety, Tolerability, and Pharmacokinetics of Intravenous Doses of PF‐07304814, a Phosphate Prodrug Protease Inhibitor for the Treatment of SARS‐CoV‐2, in Healthy Adult Participants. Issue 12 (26th October 2022) Authors: Zhu, Tong; Pawlak, Sylvester; Toussi, Sima S.; Hackman, Frances; Thompson, Kimberly; Song, Wei; Salageanu, Joanne; Winter, Erica; Shi, Haihong; Winton, Jennifer; Binks, Michael Journal: Clinical pharmacology in drug development Issue: Volume 11:Issue 12(2022) Page Start: 1382 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Domagrozumab (PF‐06252616), an Antimyostatin Monoclonal Antibody, in Healthy Subjects. Issue 5 (7th September 2017) Authors: Bhattacharya, Indranil; Pawlak, Sylvester; Marraffino, Shannon; Christensen, Jared; Sherlock, Sarah P.; Alvey, Christine; Morris, Carl; Arkin, Steven; Binks, Michael Journal: Clinical pharmacology in drug development Issue: Volume 7:Issue 5(2018) Page Start: 484 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Transplacental transfer of RSV antibody in Australian First Nations infants. Issue 2 (16th October 2021) Authors: Homaira, Nusrat; Binks, Michael; Walker, Gregory; Larter, Natasha; Clark, Katrina; Campbell, Megan; McHugh, Lisa; Briggs, Nancy; Nyiro, Joyce; Stelzer‐Braid, Sacha; Hu, Nan; Macartney, Kristine; Snelling, Tom; Omer, Saad B.; Rawlinson, William; Andrews, Ross; Jaffe, Adam Journal: Journal of medical virology Issue: Volume 94:Issue 2(2022) Page Start: 782 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗